Yajun Xu United States

Early stage Biotech investment (VC)
Partnering Objectives
Headquartner in China
Hongsen Investment
Managing partner 

Ms. Rosa Xu China

· About Us
Chairman,Mr. Rongguang WU is also the founder of Hongxing Erke , which is one of the most famous sports brands in China. We focus on investing in innovative biotech companies and healthcare funds worldwide. We have an expert team and also seek license-in opportunity of innovative drugs to develop and commercialize in China.

· Investment Cases

Previously, we've invested over 100 million dollars, more than 10 projects worldwide, including VIR Biotechnology, Beijing Genomics institution, GMAX Bio and two Top 10 biomedical funds in America, etc..

· Investment Preference

We don’t have clear limits on the investment scale and the proportion of shares, usually $5 million to $20 million of a single investment. Companies in initial stage to growth stage are all in our consideration. We can lead, co-lead, or join a round that others are leading.

Website:www.hongxingerke.com
Company Size (Fulltime employees)
Please specify your partnering goal
No clear limits
Headquartner in China
Hongxing Erke Investment Company
Investment Manager 
Functionality

Dr. Weihong Xu United States

Stanford Genome Technology Center
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
technology development partnership
Headquartner in China
Your Research Tool and Service name
genomics
SGTC
Director 

Zheng Xu China

Leading Investment and security company in China
Partnering Objectives
Headquartner in China
Guotaijunan security
Director 

shuyang xu China

天士力
Website:
www.tasly.com
Partnering Objectives
Headquartner in China
tasly
bd manager 

Dr. Chuanbo Xu United States

Liquid biopsy blood test for early detection of cancers
Website:
www.freenome.com
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
Exploring opportunities
Headquartner in China
Biotech/Pharma Category
Freenome, Inc.
Senior Director, Clinical Development 
Functionality

Shawn Xu

Simcere Innovation
Managing Director and COO 

Yuan Xudong United States

Please contact us using Acon Pharmaceutical Inc. 

Headquartner in China
Pharma - Acon Pharma
CEO 
Functionality